SCHEMBL7076298

SCHEMBL7076298

Nc1ccc(C(=O)c2cc3ccccc3[nH]2)c(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 7/20 0.59
SRC P12931 5/20 0.56
FGFR2 P21802 5/20 0.56
KDR P35968 5/20 0.56
FGFR1 P11362 4/20 0.56
FGFR4 P22455 4/20 0.56
FGFR3 P22607 4/20 0.56
PDGFRB P09619 5/20 0.50
PDGFRA P16234 5/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 1/20 0.50
DAO P14920 1/20 0.50
HPGD P15428 1/20 0.50
SRD5A2 P31213 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.49
BTK Q06187 1/20 0.47
MAP2K1 Q02750 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079332 0.79 FLT3 (0.54) FLT3SRCFGFR2KDRFGFR1
SCHEMBL31060426 0.77 FLT3 (1.00) FLT3FGFR1PDGFRBPDGFRAKDM4E
SCHEMBL370573 0.77 FLT3 (1.00) FLT3FGFR1PDGFRBPDGFRAKDM4E
Methane SCHEMBL22343918 0.75 FLT3 (0.96) FLT3FGFR1PDGFRBPDGFRAKDM4E
SCHEMBL6168778 0.75 ALOX15 (0.59) FLT3FGFR2FGFR1FGFR3PDGFRB
SCHEMBL7090488 0.75 JAK2 (0.53) KDM4EMAPTHPGDSRD5A2HSD17B10
SCHEMBL7565245 0.74 MAPK14 (0.65) FLT3SRCFGFR2KDRFGFR1
SCHEMBL6171532 0.74 ALOX15 (0.55) FLT3SRCFGFR2KDRFGFR1
Indole-2-Carboxylic Acid SCHEMBL7590299 0.74 KDM4E (0.83) FLT3PDGFRBPDGFRAKDM4EMAPT
SCHEMBL7080355 0.74 MAPT (0.47) KDM4EMAPTHSD17B10ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 FLT3 1230/4885SRC 912/4885FGFR2 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.